Assignment On

Industry Profile: Pharmaceutical Industry

Course Name Course Code

: Business Communication : Bus - 214

Submitted To : Tanvir Ahmed Torophder Lecturer.

Submitted By Name Sarwar Rashid Mozumdar Mazidur Rahaman Muminul Hoque Rumanaz Parvin Sumit Karmakar Topu Roy

: ID 1003010004 1003010006 1003010022 1003010011 1003010032 1003010039

26th Batch (Fall Semester).

Department of Business Administration Leading University, Sylhet. Date of Submission : 2 November, 2011.

Leading University, Sylhet

Letter of Certificate
I am extremely pleased to declare that the following group of students has been given with the topic Pharmaceutical Industry" for writing a report. They have reviewed all the relevant literature for collecting of data. I have supervised them throughout the preparation of the paper. I also certify that the paper is an original one and has not been submitted elsewhere previously for publication in any form. I believe they will try to do their best in all phase of their live.

Tanvir Ahmed Torophder Lecturer Department of Business Administration Leading University, Sylhet

2nd November, 2011 To, Tanvir Ahmed Torophder Lecturer Department of Business Administration Leading University, Sylhet Subject: Letter of Submittal / Submission. Dear Sir, We were given the topic A study on Pharmaceutical Industry" for writing a report for presentation and collection of primary and secondary data. To do so, we sought the relevant information in books, journals, and the assigned organization. We tried to collect all possible information and make this paper acceptable to all but there can be still existing mistake. So we like to request you to consider if any fault is found in paper. Lastly, we would like to request you to accepted our paper and permit us to present it before the panel of experts. Thank you in advance for your assistance and advice in this connection. Yours obediently

Name Sarwar Rashid Mozumdar Mazidur Rahaman Muminul Hoque Rumanaz Parvin Sumit Karmakar Topu Roy

ID 1003010004 1003010006 1003010022 1003010011 1003010032 1003010039

Acknowledgement
This is to thank our honorable teacher Tanveer Ahmad Topadar for assigning us to prepare an assignment on a topic which is very important and also interesting. It is prepared following all suggestion of our course teacher and we tried to make no mistake while preparing this assignment. Though we have collected information from book, website and also class lecture of our teacher. We would like to thank our honorable teacher Tanveer Ahmad Topadar and again sorry if we have any mistake while making this assignment.

Limitation of the study

Lack of information available Lack of assistance from the Company people Shortage of time Not much specific information regarding the Organization

Table of Content
Pharmaceutical Industry. Background. Products. Production Volume. Name of Companie s. Major Players. Export. Prospects.

Pharmaceutical Industry
Pharmaceutical industry develops, produces, and markets drugs licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and brand medications and medical devices. They are subject to a variety of laws and regulations regarding the patenting, testing and ensuring safety and efficacy and marketing of drugs.

Background of Pharmaceutical Industry

The total industry can broadly be classified into two categories: a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company, who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic medicines are the products that are produced in mass scale. These are marketed by several companies under different brand name, where the formulation of this product is almost same. Prices of the products are under this category are competitive. Bangladesh mainly concentrates on this category, as labor cost is one of the lowest in the world.

The Rise of Pharmaceutical Sector of Bangladesh

In Bangladesh Pharmaceutical sector is one of the most developed hi-tech sector which is contributing in the country's economy. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The professional knowledge, thoughts and innovative ideas of the pharmacists working in this sector are the key factors for this development. Due to recent development of this sector we are exporting medicines to global market including European market. This sector is also providing 95% of the total medicine requirement of the local market. Leading Pharmaceutical Companies are expanding their business with the aim to expand export market. Recently few new industries have been established with hi-tech equipments and professionals which will enhance the strength of this sector.

Bangladesh Association of Pharmaceutical Industries (BAPI), the stalwart association of pharmaceutical manufacturers of the country was instituted in 1972, since then BAPI playing a pivotal role in shaping up the industry. Association's member include large, medium, small, national and foreign companies who together are responsible for manufacturing 96% of the country's pharmaceutical production. This indeed proves the success of BAPI as a responsible and acceptable body.

Products
UNANI: The Directorate of Drugs Administration under the Ministry of Health & Family Welfare, Govt. of Bangladesh, is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import and procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani and Homoeopathic systems. At present, there are 295 Unani companies operating in Bangladesh.

AYURVEDIC: The Directorate of Drugs Administration under the Ministry of Health & Family Welfare, Govt. of Bangladesh, is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import and procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani and Homoeopathic systems. At present, there are 201 Ayurvedic companies operating in Bangladesh.

HERBAL: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Govt. of Bangladesh, is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import and procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani, Homoeopathic and Herbal systems. At present, there are 15 Herbal companies operating in Bangladesh.

HOMEOPATHIC: The Directorate of Drugs Administration under the Ministry of Health & Family Welfare, Govt. of Bangladesh, is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import and procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani and Homoeopathic systems. At present, there are 79 Homeopathic companies operating in Bangladesh.

ALLOPATHIC: The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Govt. of Bangladesh, is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import and procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani and Homoeopathic systems. At present, there are 258 Allopathic companies operating in Bangladesh.

Tablets: Non-Coated (plain, chewable, dispersible, vaginal)

Coated (sugar coated, film coated, enteric coated) Sustained/Extended Released (coated, non coated)

Capsules: Granulated Material filled

Pellets Filled

Suppositories: Suppository based Injections: Vials containing Dry Powder for Injections
Small Volume Liquid Potentials

Liquids: Oral Syrups (Sugar based, Non-Sugar based)

Oral Suspensions Topical Liquids Spray, Drops, Ointment, Cream and Powder: Small Volume Sterile Eye & Ear Drops Small Volume Nasal Drops & Sprays Topical Ointments & Creams Topical Antibiotic Powder

Oral Dry Powders: Dry Suspensions (Antibiotic & Anti Infective)

Dry Syrups (Antibiotics) Dry Powder Inhalers: Partial Filled (Premix) Capsules for Respiratory Tract Application with a Device Metered Dose Inhalers: Pressurized Canisters for Oral use with an Actuator Pre-filled Syringe Injection: The advanced potential technology.

Production Volume Bangladeshs largest Pharma Companies Companies Name Square Incepta Beximco Acme Eskayef ACI Opsonin Renata Aristopharma Production Volume $138.7 $ 52.1 $ 49.0 $ 36.3 $ 32.1 $ 31.3 $ 29.7 $ 29.1 $ 28.8

Name of Companies

Advanced Chemical Industries (ACI) Limited The ACME Laboratories Ltd Amico Laboratories Aristo pharma Ltd Beacon Pharmaceuticals Ltd. Beximco Pharma Bristol Pharma Ltd Delta Pharma Limited. Eskayef Bangladesh Limited Gaco Pharmaceutical Limited UniMed & UniHealth Pharma Limited GlaxoSmithKline Bangladesh Ltd. Globe Pharmaceutical Limited Healthcare pharmaceuticals Limited IBN Sina Incepta Pharmaceuticals Monico Pharma Ltd. Bangladesh Novo Healthcare & Pharma Limited Opsonin Pharma Limited Orion Pharma Limited Paradise Chemical Industries Popular Pharmaceuticals Limited

Renata Limited Syntho Laboratories Limited Silva Pharmaceutical Limited Square Pharmaceuticals Supreme Pharmaceuticals Limited Jayson Pharmaceutical Limited Sonear Laboratories Limited Zenith Pharmaceuticals Ltd.

Major Players
ACI
ACI was established as the subsidiary of Imperial Chemical Industries (ICI) in the then East Pakistan in 1968. After independence the company has been incorporated in Bangladesh on the 24th of January 1973 as ICI Bangladesh Manufacturers Limited and also as Public Limited Company. This Company also obtained listing with Dhaka Stock Exchange on 28 December, 1976 and its first trading of shares took place on 9 March, 1994. Later on 5 May, 1992, ICI plc divested 70% of its shareholding to local management. Subsequently the company was registered in the name of Advanced Chemical Industries Limited. Listing with Chittagong Stock Exchange was made on 22 October 1995.

Beximco
Beximco Pharma started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA. It has now grown to become a leading pharmaceutical company in Bangladesh, and it supplies more than 10% of country's total medicinal needs. Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets.

Square
The company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It went public in 1991 and is currently listed on the Dhaka Stock Exchange. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and it has been continuously in the 1st position among all national and multinational companies since 1985. Square Pharmaceuticals Ltd. is now on its way to becoming a high performance global player.

Renata
Renata Limited (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata, is one of the top ten (in terms of revenue) pharmaceutical manufacturers in Bangladesh. Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products. The company also manufactures animal therapeutics and nutrition products. Renata currently employs about 2300 people in its head office in Mirpur, Dhaka and its two production facilities in Mirpur, Dhaka and Rajendrapur, Dhaka.

Incepta
Incepta Pharmaceuticals was established in 1999 and produced its first product, ranitidine, in December of that year. The company's manufacturing facility is located 35 miles from Dhaka in Savar, where they produce various types of drug dosage forms such as tablets, capsules, oral liquids, injections, and nasal sprays. The companys specialties include sustained-release tablets, quick-dissolving oral tablets, and barrier-coated delayed-release tablets. Incepta also conducts research and development on advanced dosage forms for various drugs and devices including poorly-soluble drugs, dry powder inhalers, coated pellets, modified-release products, and taste-masked preparations. The company sells its products in Bangladesh and plans to begin exporting to both developed and developing countries around the world.

Export

It is very encouraging news that Bangladesh has became a drug exporting country instead of importing one. The statistics of last five years drug export are as follows: 2006 2007 2008 2009 2010 2663.39 million taka 2477.41 million taka 3277.19 million taka 3471.69 million taka 3813.50 million taka

It is indeed good news that at present drugs are exported to 83 countries including Europe and America and other countries. The quantity of drugs & the number of countries are increasing day by day by active support and efforts of present government. At present Bangladesh exports formulated medicines about 83 countries in the world. Some of the countries name mention below: Australia, Austria, France, Columbia, Vietnam, Greece, Sri Lanka, Malaysia, Finland, Sweden, UK, Hong Kong, Nether land, Norway, Thailand, Brazil, Venezuela, Mexico, Philippines, Egypt, Pakistan, Ukraine, Curacao, Indonesia, Russia, South Africa, Jordan, USA, Iran, Japan, Korea, Yemen, Bhutan, Guinea, Nepal, Sudan, Kenya, Myanmar, Ghana, KSA, Kosovo, Papua New Guinea, Mauritius, Singapore, Afghanistan, Malta etc. We are very optimistic that very soon; the pharmaceutical sector of Bangladesh would be able to occupy a prestigious position in the international arena by the dynamic leadership of the present government of Bangladesh.

Prospects
In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which are contributing in the countrys economy. With an annual turnover of about $715 million, Bangladesh's pharmaceutical industry is one of the fast growing sectors in Bangladesh. There are about 231 companies in this sector and the approximate total market size is about $650 million per year of which about 95% of the total requirement of medicines is created by the local companies and the rest 5% is imported. The imported drugs mainly comprise of the cancer drugs, vaccines for viral diseases, hormones etc. Among the 49 least developed countries (LDCs), Bangladesh is the only country that is nearly self-sufficient in pharmaceuticals